Peptide Purity, Identity, Safety & Stability Testing for Anti-Aging Therapies, Cosmetics, Pharmaceuticals & Research Compounds — UAE

Peptides are among the fastest-growing categories in the UAE’s healthcare, anti-aging, and wellness sectors. From collagen-stimulating cosmetic peptides and anti-aging serums to physician-prescribed therapeutic peptides administered in DHA and DOH-licensed clinics, demand for analytically verified, regulatory-compliant peptide products has never been higher. Unverified peptide batches — whether mislabelled, impure, degraded, or contaminated — pose serious safety risks and create significant legal exposure for clinics, formulators, importers, and compounding pharmacies operating under the UAE’s stringent MOHAP, DHA, and DOH frameworks. As one of the leading peptide testing laboratories in UAE, METS Lab provides independent, analytical testing services covering the complete range of peptide quality parameters — from purity and identity to impurity profiling, endotoxin detection, residual solvent analysis, heavy metal screening, and stability testing. Our results underpin Certificate of Analysis (CoA) documentation, MOHAP/DHA product dossiers, compounding pharmacy quality records, and cosmetic product safety assessments. Whether you are a cosmetic formulator, a UAE-licensed compounding pharmacy, a clinical research organisation, a peptide importer, or an anti-aging wellness clinic requiring third-party batch verification — METS Lab delivers the analytical rigour and regulatory credibility your products demand.

Our Core Peptide Testing Services Include

• Peptide Purity Testing by RP-HPLC (Reverse-Phase High-Performance Liquid Chromatography)
• Peptide Identity Confirmation by LC-MS / ESI-MS
• Amino Acid Analysis (AAA) & Net Peptide Content (NPC) Determination
• Peptide Sequence Verification by LC-MS/MS (Tandem Mass Spectrometry)
• Impurity Profiling & Related Substance Testing
• Bacterial Endotoxin Testing (BET / LAL Assay) — USP <85> / Ph. Eur. 2.6.14
• Residual Solvent Analysis by GC-MS / Headspace GC — ICH Q3C / USP <467>
• Heavy Metal & Elemental Impurity Testing by ICP-MS — USP <232> / ICH Q3D
• Microbiological Testing — USP <61> / <62> / ISO 21149
• Peptide Stability Testing — ICH Q1A(R2)
• Water Content Determination by Karl Fischer Titration — USP <921>
• Enantiomeric Purity Testing by GC-MS
• Anti-Aging & Cosmetic Peptide Characterization

Why Peptide Testing Is Critical in the UAE?

Peptide Purity Testing by RP-HPLC

Purity is the foundational quality parameter for any peptide product. Reverse-phase high-performance liquid chromatography (RP-HPLC) separates the target peptide from synthesis by-products, truncated sequences, deletion impurities, oxidation products, and residual reagents based on differential hydrophobic interactions with a reversed-phase stationary phase. The relative peak areas in the resulting chromatogram are used to calculate purity as a percentage of total UV-absorbing material. For pharmaceutical-grade peptides used in UAE-licensed compounding pharmacies and DHA/DOH-regulated clinics, purity requirements of ≥98% are standard. Cosmetic peptide actives typically require ≥95% purity for incorporation into registered personal care products. Anti-aging peptides marketed in the UAE — whether in injectable, topical, or oral formulations — must demonstrate purity through batch-specific, third-party RP-HPLC data to satisfy MOHAP and EDE documentation requirements. METS Lab performs peptide purity testing in compliance with the following references:

• Chromatography — General Principles (HPLC method validation and system suitability) — USP <621>
• Validation of Analytical Procedures (method validation for purity determination) — ICH Q2(R1)
• European Pharmacopoeia monographs for synthetic peptides (RP-HPLC purity) — Eur. 2.2.29
• FDA Guidance for Industry: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products — FDA Guidance 2021

Peptide Identity Confirmation by LC-MS / ESI-MS / MALDI-TOF

Purity data alone cannot confirm what a peptide actually is. A sample may be 99% pure and still be the entirely wrong compound. Mass spectrometry (MS) answers the identity question by measuring the precise molecular weight of the peptide and comparing it to the theoretical mass calculated from the amino acid sequence. A molecular weight match confirms the compound is the stated peptide; a mismatch — even by a single dalton — is grounds for batch rejection. METS Lab offers mass spectrometry approaches for peptide identity confirmation: Electrospray ionisation mass spectrometry for peptide characterisation (ESI-MS/MS) — USP <1058> / ICH Q6A

• MALDI-TOF mass spectrometry — molecular weight determination of peptides and proteins — ISO 23118
• High-resolution tandem mass spectrometry — peptide sequence confirmation — ICH Q6B / Ph. Eur. 2.2.43

Amino Acid Analysis (AAA) & Net Peptide Content (NPC) Determination

Not everything in a peptide vial is peptide. Lyophilised peptide products typically contain water, counterions (trifluoroacetate, acetate, hydrochloride), residual solvents, and inorganic salts that contribute to the total mass without contributing to peptide activity. Net peptide content (NPC) determination quantifies the true peptide fraction as a percentage of total mass — a critical parameter for accurate dosing, particularly in therapeutic and clinical applications. Amino acid analysis (AAA) is the reference method for NPC determination. The peptide is hydrolysed to its constituent amino acids, which are then separated and quantified by chromatographic methods. The resulting amino acid molar ratios confirm both the composition and the quantity of the peptide present. In the UAE context, where physician-prescribed peptides used for anti-aging, metabolic health, and regenerative medicine must meet exacting dosing specifications, NPC data is a mandatory element of batch documentation. Testing follows the following reference methods:

• Amino acid analysis — hydrolysis and derivatisation methods for quantitative AAA — USP <1052>
• Net peptide content determination using amino acid analysis — Eur. 2.2.56
• Elemental analysis as an alternative NPC determination method (nitrogen content) — AOAC 992.23

Peptide Sequence Verification by LC-MS/MS

For novel, complex, or regulatory-critical peptides, confirmation of the correct amino acid sequence — not just molecular weight — is required. Liquid chromatography tandem mass spectrometry (LC-MS/MS) provides fragment-level mass data by systematically fragmenting the peptide ion and recording the masses of the resulting b-ion and y-ion series. By matching the observed fragment pattern to the predicted fragmentation of the target sequence, laboratories can confirm the correct amino acid order, identify substitutions or deletions, and characterize post-translational or chemical modifications. Sequence verification by LC-MS/MS is particularly relevant for high-value anti-aging peptides, complex multi-residue therapeutic peptides, and any peptide subject to regulatory scrutiny in the UAE. METS Lab performs sequence verification in compliance with:

• High-resolution tandem MS — sequence confirmation of synthetic peptides — ICH Q6B / Ph. Eur. 2.2.43

Impurity Profiling & Related Substance Testing

Peptide synthesis is a chemically complex process; even optimized solid-phase peptide synthesis (SPPS) generates a spectrum of process-related impurities including truncated sequences (deletion peptides), racemized amino acid residues (epimers), oxidized methionine or cysteine residues, deamidated asparagine residues, and coupling by-products. These impurities can reduce potency, generate immunogenic responses, or confound research results — making comprehensive impurity profiling an essential quality control step. METS Lab’s impurity profiling service applies RP-HPLC and UPLC-MS to characterize and quantify related substances in peptide batches, providing a full impurity profile rather than just a single purity percentage. This level of analytical detail is increasingly required by UAE regulatory authorities for pharmaceutical-grade peptides and is best practice for anti-aging and cosmetic peptide actives. Impurity profiling follows:

• Control of impurities in substances for pharmaceutical use — ICH Q3A(R2)
• Impurities in new drug products — ICH Q3B(R2)
• RP-HPLC and UPLC-MS impurity profiling of synthetic peptides — Eur. 2.2.29 / USP <621>
• Enantiomeric purity (D-amino acid content) by GC-MS after hydrolysis and derivatization — Eur. 2.2.46

Bacterial Endotoxin Testing (BET / LAL Assay)

Bacterial endotoxins — lipopolysaccharides (LPS) shed from the outer membrane of Gram-negative bacteria — are potent pyrogenic contaminants capable of triggering severe inflammatory responses at remarkably low concentrations. For peptides intended for parenteral administration (subcutaneous or intramuscular injection), as is standard practice in UAE anti-aging and regenerative medicine clinics administering peptides such as BPC-157, TB-500, CJC-1295, and Ipamorelin, endotoxin levels must be rigorously controlled and documented. METS Lab performs bacterial endotoxin testing using the Limulus Amebocyte Lysate (LAL) assay, the internationally accepted reference method for endotoxin quantification. Results are reported in Endotoxin Units per milligram (EU/mg). Injectable peptide products compounded in UAE-licensed pharmacies under MOHAP and EDE oversight must meet defined endotoxin limits — typically ≤1.0 EU/mg for parenteral products — and batch-specific endotoxin data is a mandatory component of every CoA. Testing is performed in compliance with:

• Bacterial endotoxins test (LAL gel-clot and kinetic turbidimetric methods) — USP <85>
• Test for bacterial endotoxins — Eur. 2.6.14

Residual Solvent Analysis by GC-MS / Headspace GC

Peptide synthesis relies on a range of organic solvents — including acetonitrile, dimethylformamide (DMF), dichloromethane (DCM), trifluoroacetic acid (TFA), methanol, and diethyl ether — during SPPS coupling and purification steps. Incomplete removal of these solvents during lyophilization results in residual solvent contamination in the final product. TFA is of particular concern for injectable peptides: its G-protein-coupled receptor activity at supra-physiological concentrations can confound biological assays and presents a direct safety concern in human-use products. METS Lab quantifies residual solvents in peptide samples by gas chromatography-mass spectrometry (GC-MS) and headspace GC, applying ICH Q3C classification limits to categories solvents by toxicological risk (Class 1: carcinogens/genotoxins to avoid; Class 2: solvents with permitted daily exposure limits; Class 3: solvents with low toxic potential). Testing complies with:

• Residual solvents — classification and limits for pharmaceutical products — ICH Q3C (R8)
• Residual solvents testing by headspace GC — USP <467>
• Residual solvents in pharmaceuticals — Eur. 2.4.24

Heavy Metal & Elemental Impurity Testing by ICP-MS

Elemental impurities in peptide products may arise from synthesis catalysts, reagents, purification media, or equipment contact surfaces. Heavy metals including lead, arsenic, mercury, and cadmium are acutely toxic; other elements such as nickel, palladium, and platinum arise from catalysts used in certain peptide coupling steps. ICH Q3D and its pharmacopoeia implementations establish permitted daily exposures (PDEs) for 24 elemental impurities, classified by route of administration. For peptides administered by injection — the dominant route in UAE anti-aging and wellness clinics — elemental impurity limits are stringent, reflecting the absence of oral bioavailability barriers. METS Lab performs elemental impurity analysis by inductively coupled plasma mass spectrometry (ICP-MS), the high-sensitivity reference technique for trace metal quantification, in compliance with:

• Elemental impurities in pharmaceuticals — risk assessment and limits — ICH Q3D (R2)
• Elemental impurities — inductively coupled plasma mass spectrometry (ICP-MS) — USP <232> / <233>
• Elemental impurities in medicinal products — Eur. 2.4.20

Microbiological Testing — Bioburden & Sterility

Peptide products administered to patients in UAE clinics must meet strict microbiological standards. Microbial contamination of peptide batches — whether from synthesis, handling, packaging, or storage — can cause serious infections, particularly in immunocompromised patients or where injection is the route of administration. Microbiological testing encompasses bioburden determination, absence of specified pathogens, and sterility testing for products claiming to be sterile. METS Lab performs microbiological testing in compliance with pharmacopoeia and international standards, covering total aerobic microbial count (TAMC), total yeast and mould count (TYMC), absence of specified organisms (Salmonella, E. coli, Staphylococcus aureus, Pseudomonas aeruginosa), and sterility testing for injectable peptides. Testing is conducted in accordance with:

• Microbiological examination of non-sterile products — microbial enumeration tests — USP <61> / Ph. Eur. 2.6.12
• Microbiological examination — tests for specified micro-organisms — USP <62> / Ph. Eur. 2.6.13
• Sterility testing for pharmaceutical products — USP <71> / Ph. Eur. 2.6.1
• Microbiological testing of cosmetics — ISO 21149

Peptide Stability Testing — ICH Q1A(R2)

Peptides are structurally sensitive molecules susceptible to degradation through hydrolysis, oxidation, aggregation, racemisation, and disulphide bond scrambling. Stability data is essential to establish appropriate shelf life, storage conditions, and packaging specifications — and is required by UAE regulators, MOHAP, and international authorities for pharmaceutical and cosmetic peptide product registrations. METS Lab provides peptide stability testing studies in climate-controlled chambers at conditions defined by ICH Q1A(R2) — long-term (25°C/60% RH), intermediate (30°C/65% RH), and accelerated (40°C/75% RH) — with analytical testing at defined time-points covering purity, identity, impurity profile, and physical appearance. Stability studies are conducted in accordance with:

• Stability testing of new drug substances and products — ICH Q1A(R2)
• Photostability testing of new drug substances and products — ICH Q1B
• Evaluation of stability data — ICH Q1E

Commonly Tested Peptides for Anti-Aging & Wellness in UAE

The UAE’s rapidly growing anti-aging and longevity medicine sector has created significant demand for verified, analytically characterised peptide products. METS Lab routinely provides purity, identity, and safety testing for the following categories of peptides prominently used by UAE clinics, wellness centres, compounding pharmacies, and cosmetic formulators:

• GHK-Cu (Copper Tripeptide-1) — collagen synthesis, skin rejuvenation, wound healing
• Argireline (Acetyl Hexapeptide-8) — topical anti-wrinkle, neuromodulatory mechanism
• Matrixyl / Palmitoyl Pentapeptide-4 — collagen and hyaluronic acid stimulation in anti-aging serums
• BPC-157 (Body Protection Compound) — tissue repair and regenerative medicine
• Thymosin Beta-4 (TB-500) — tissue regeneration, anti-inflammatory applications
• CJC-1295 & Ipamorelin — growth hormone secretagogues, used under physician prescription
• Semaglutide & GLP-1 Receptor Agonist Peptides — metabolic health, weight management
• Selank & Semax — cognitive enhancement and neuroprotective research
• Epithalon (Epitalon) — anti-aging, telomere-associated research applications
• Collagen Peptides (Hydrolysed Collagen) — food supplements, skin health
• Melanotan II — pigmentation and tanning research compounds

Industries We Serve

Our facility provides specialised peptide analytical services across a wide range of sectors in the UAE and wider GCC. We help clients validate product quality, support regulatory submissions, generate Certificate of Analysis documentation, and ensure patient and consumer safety:

• UAE-Licensed Compounding Pharmacies (MOHAP / EDE regulated)
• Anti-Aging, Longevity & Regenerative Medicine Clinics (DHA / DOH licensed)
• Cosmetic & Skincare Formulators (anti-aging peptide actives)
• Pharmaceutical Importers & Distributors
• Peptide Manufacturers & API Suppliers
• Nutraceutical & Dietary Supplement Producers (collagen peptides, bioactive peptides)
• Contract Research Organisations (CROs) & Clinical Investigators
• Universities & Research Institutions
• Wellness Centres & Aesthetic Medicine Clinics
• Regulatory Affairs & Quality Assurance Consultants

Why Choose METS Lab for Peptide Testing in UAE?

As a leading peptide testing laboratory in UAE, we combine advanced analytical instrumentation with deep expertise in pharmacopoeial and ICH-compliant testing methods to deliver results that satisfy the most demanding regulatory requirements: Complete Peptide Report Generation: We provide comprehensive batch-specific Certificate of Analysis documentation covering all critical parameters — purity, identity, net peptide content, endotoxin, residual solvents, elemental impurities, and microbiological results — in a single consolidated report. Independent Third-Party Verification: As an independent laboratory with no commercial interest in peptide supply or sales, METS Lab provides unbiased analytical verification — the gold standard for regulatory submissions, supplier qualification audits, and consumer trust in the UAE’s anti-aging and wellness sector. Advanced Instrumentation: Our analytical capabilities include RP-HPLC, UPLC-MS, LC-MS/MS, ICP-MS, GC-MS, headspace GC, Karl Fischer titration, etc,— covering the complete portfolio of analytical techniques required for comprehensive peptide characterization

FAQ — Peptide Testing Laboratory in UAE

Why is third-party peptide testing important in the UAE?

The UAE’s anti-aging, wellness, and pharmaceutical sectors have seen a rapid increase in peptide products of varying provenance and quality. Unverified peptides may contain incorrect sequences, low purity, dangerous contaminants, or incorrect concentrations — posing direct patient safety risks and creating legal exposure for clinics and pharmacies under MOHAP and DHA oversight. Third-party testing by an ISO/IEC 17025:2017-accredited laboratory such as METS Lab provides independent, unbiased analytical verification that satisfies regulatory requirements and protects both practitioners and patients.

What is RP-HPLC and why is it the standard method for peptide purity testing?

Reverse-phase high-performance liquid chromatography (RP-HPLC) is the universally accepted reference method for peptide purity determination. It separates the target peptide from impurities based on hydrophobic interactions with the stationary phase, producing a chromatogram where each component appears as a distinct peak. The purity is calculated as the percentage of the total peak area represented by the main peptide peak. RP-HPLC is sensitive, reproducible, and accepted by all major pharmacopoeias and regulatory authorities including USP, Ph. Eur., FDA, and MOHAP-aligned frameworks.

Can HPLC purity alone confirm a peptide is what it claims to be?

No. HPLC confirms purity — how much of a single compound is present — but cannot confirm which compound it is. A sample could be 99% pure and still be the completely wrong peptide. Mass spectrometry (ESI-MS, MALDI-TOF, or LC-MS/MS) is always required alongside HPLC to confirm identity by matching the measured molecular weight to the theoretical mass of the target sequence. METS Lab always recommends combined HPLC and MS as the minimum analytical package for any peptide batch verification.

What endotoxin limit applies to injectable peptides used in UAE clinics?

For parenteral (injectable) pharmaceutical products, the general endotoxin limit is typically ≤5.0 EU/kg body weight/hour, which for most injectable peptide products translates to a product specification of ≤1.0 EU/mg as a conservative and widely adopted limit for compounded injectables. UAE-licensed compounding pharmacies operating under MOHAP and EDE oversight must document endotoxin testing results in batch records. METS Lab performs endotoxin testing by the Limulus Amebocyte Lysate (LAL) assay per USP <85> and Ph. Eur. 2.6.14.

Do cosmetic anti-aging peptides (serums, creams) need the same testing as injectable peptides?

The testing scope differs by risk profile and regulatory category. Injectable peptides require the most comprehensive testing including endotoxin, sterility, and elemental impurities at parenteral limits. Cosmetic anti-aging peptide actives used in serums and creams — such as Argireline, Matrixyl, or GHK-Cu — require purity, identity, heavy metal screening (MOHAP cosmetic limits), and microbiological testing per ISO 21149, but not sterility or parenteral endotoxin limits. METS Lab advises clients on the appropriate test scope based on the product category and intended route of use.

What is net peptide content (NPC) and why does it matter for anti-aging peptides?

Net peptide content (NPC) is the true percentage of actual peptide in a lyophilised product, after accounting for water, residual salts, counterions (such as TFA), and other non-peptide components that contribute to total mass. A vial labelled as containing 5 mg of peptide may actually contain only 3.5 mg of active peptide if NPC is not determined and corrected for. For anti-aging therapy protocols requiring precise dosing — as is standard in UAE clinics administering peptides such as BPC-157, CJC-1295, or Ipamorelin — NPC data is essential for accurate, safe, and reproducible dosing.

How long does peptide testing take at METS Lab?

Turnaround time depends on the test scope. Standard purity (RP-HPLC) and identity (ESI-MS) testing typically completes within 7-10 business days from sample receipt. Comprehensive CoA packages including endotoxin, residual solvents, elemental impurities, and microbiological testing typically require more time. Stability study initiation can be arranged immediately, with interim reports issued at the defined time-points. Rush turnaround options are available — contact us at project initiation to discuss your timeline and requirements.

Need peptide testing in UAE? Share your project details with METS Lab and we will provide a personalized testing proposal and quote tailored to your product, regulatory requirements, and timeline.